Picture: Valneva SE

French Valneva appoints new CMO

In October Juan Carlos Jaramillo will take over the business from Wolfgang Bender as new Chief Medical Officer and member of the Valneva Management Board.

After a hand-over period Bender will retire at the end of October. Jaramillo brings an international experience and strong expertise in Medical Affairs and Clinical Development that includes vaccines, as well as global market access. He has worked in various pharmaceutical and biotech companies, including GlaxoSmithKline and Grünenthal. In the last eight years, the native Colombian with US citizenship was Head of Global Market Access & Pricing at Daiichi Sankyo.